Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The AI-guided robotic surgery market was valued at USD 3.15 Billion in 2025 and is expected to reach USD 22.08 Billion by 2035, growing at a CAGR of 21.50% during 2026-2035. Growth stems from a large installed base of robotic platforms, regulatory clearances for AI-enabled functions, expanding surgical video datasets and progress toward higher autonomy levels.
Patent activity has accelerated since 2020, with more than 2,400 families filed worldwide. Filings concentrate in computer vision, autonomous task execution, preoperative planning and force estimation, and commercial validation includes force-sensing da Vinci 5 launches and image-guided orthopaedic and spine platforms.
This AI-Guided Robotic Surgery Patent Landscape Analysis Report maps assignees, jurisdictions and technology clusters to support portfolio, partnering and freedom-to-operate decisions.
The AI-guided robotic surgery market is experiencing strong growth, driven by a large installed base of robotic platforms, regulatory clearances for AI-enabled functions, and rising adoption of higher autonomy levels. Intuitive Surgical reported over 2.6 million procedures in 2024, giving AI software a large base on which to scale.
Patent activity is accelerating, with 50+ AI-guided robotic surgery patents granted in 2025, reflecting strong innovation momentum in surgical scene understanding, autonomous task execution, AI-driven preoperative planning, and machine-learning force estimation.
Top assignees in the AI-guided robotic surgery patent landscape include Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, Stryker, and Zimmer Biomet, with the United States, China, and Europe as the dominant patent jurisdictions.
AI-guided robotic surgery combines robotic platforms with computer vision, machine learning and planning software to assist or partially automate operative steps. Demand grows with the volume of minimally invasive procedures, a global surgeon shortage in several specialties and the need for consistent outcomes in hernia, prostate, colorectal, knee and spine surgery.
North America leads the market, supported by high robotic procedure volumes, favourable reimbursement and rapid FDA clearance of software features. Europe follows with strong adoption in Germany, France and the United Kingdom, while Asia-Pacific shows the fastest growth as China and Japan scale domestic platforms and public tenders.
The high growth rate reflects an AI layer scaling over a large robotic installed base, with Intuitive Surgical alone reporting more than 2.6 million procedures in 2024. Recent FDA clearances for AI-enabled functions and the move from level 1 assistance toward level 2 and 3 task autonomy add recurring software revenue.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Patent filings in AI-guided robotic surgery follow the growth of robotic procedure volumes and of annotated surgical datasets. Applicants file on image-based instrument tracking, anatomy segmentation, tissue-aware motion planning and learned force models. Filings from technology firms and university hospitals now sit alongside those from device manufacturers.
More than 2,400 patent families exist worldwide, with peak filing years in 2021 to 2024. Roughly 50 patents were granted in 2025, led by US and Chinese offices. Medical imaging, robotic control and machine-learning classes dominate new applications.
Rising robotic procedure volumes and AI clearances raise the commercial value of software claims, which pushes assignees to file in vision, autonomy and planning.
The report covers granted patents and published applications on AI methods applied to robotic surgery systems, including perception, planning, control, analytics and remote operation. It includes software, instruments, sensors and system architectures where the claims recite a learned or data-driven function.
Analysis spans patent families filed from 2010 to 2026, grouped by technology cluster, application, platform type and assignee. Legal status, citation intensity and filing trajectory are reviewed for each cluster.
Entities covered include device manufacturers, orthopaedic and spine robotics companies, imaging and navigation specialists, artificial intelligence start-ups, universities and academic medical centres.
The report will cover the following sections in detail:
Analysis by Technology
Analysis by Application
Analysis by Platform Type
AI-Guided Robotic Surgery Patent Filing Trend Analysis
Filings in AI-guided robotic surgery grew at an estimated 18% to 22% per year over 2020 to 2024. Growth came from deep-learning methods for scene segmentation, larger annotated video libraries and the commercial launch of next-generation platforms.
Autonomy-related filings rose fastest, supported by research demonstrations of autonomous suturing and tissue tracking. Telesurgery filings gained momentum after long-distance procedures over 5G and dedicated networks drew regulatory attention in China and the United States.
Among the players with AI-guided robotic surgery patent families, new entrants have been identified, which can be either established companies or startups developing novel technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
Intuitive Surgical holds the largest portfolio in AI-guided robotic surgery, spanning instrument control, endoscopic imaging, kinematics, simulation and machine-learning analysis of surgical video. Its da Vinci Xi and da Vinci 5 platforms, the latter cleared by the US FDA in 2024 with force feedback instruments and a large computing upgrade, anchor the commercial franchise. The Ion bronchoscopy platform extends the portfolio into image-guided navigation. The company files continuations around core system architecture and builds data assets from procedure recordings and the My Intuitive and Case Insights applications. Its installed base above 10,000 systems gives its AI claims a direct route to deployment.
Medtronic holds the second-largest portfolio, covering the Hugo robotic-assisted surgery system, Mazor spine robotics, StealthStation navigation and the Touch Surgery ecosystem for video analytics. Hugo received FDA clearance for urologic procedures, adding to CE marking and approvals in several Asia-Pacific markets. The company files heavily in surgical video capture, AI-based step recognition, cloud analytics and image-guided spine workflows. Its strategy pairs a modular platform with a software layer that works across robotic and laparoscopic cases. Commercial positioning targets hospitals seeking a second platform option alongside established incumbents.
Other companies include Johnson & Johnson MedTech, Stryker and Zimmer Biomet.
The top five assignees hold an estimated 30% to 35% of families, with Intuitive Surgical and Medtronic together near 15%. The remainder is spread across orthopaedic robotics firms, imaging specialists, universities and start-ups, which indicates a moderately concentrated field.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The report assesses patent activity across major jurisdictions, including:
The United States leads by filing volume, followed by China and Europe. China shows the steepest growth, driven by domestic platform makers and university hospitals, while Europe features Brainlab, CMR Surgical and Zimmer Biomet's European filings.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report segments patent activity by the following technology areas:
Among these, computer vision and scene understanding holds the largest share of families, since perception underpins every higher autonomy function.
Intuitive Surgical and Medtronic lead the field, followed by Johnson & Johnson MedTech (Ethicon and Verb Surgical lineage). Stryker with its Mako platform and Zimmer Biomet with ROSA. Globus Medical, CMR Surgical and Brainlab hold focused portfolios in spine navigation, modular soft tissue platforms and image guidance.
Companies are focusing on:
Emerging innovation themes include foundation models trained on surgical video, supervised autonomy for suturing and dissection, digital twins for case rehearsal, and 5G-enabled remote operation. Cloud-connected analytics that benchmark surgeon performance also draw growing filings.
The field combines a few device incumbents with deep installed bases and many software entrants. Incumbents file broadly around platform architecture, while specialists protect narrow algorithms for segmentation, planning and force sensing.
Technology segments, application areas and assignee portfolios are tracked to give the report its decision value. The report provides actionable intelligence supporting:
The study searched patent records from the USPTO, EPO, WIPO, CNIPA, JPO and KIPO, with commercial databases used for family consolidation. Queries combine CPC classes A61B 34/00, A61B 34/30, A61B 90/37, G06T 7/00, G06N 3/08 and G16H 20/40 with keyword sets for surgical vision, autonomy and planning.
Records were screened by title, abstract and claims, then grouped into simple families. Granted patents, pending applications and legal status were tagged, and each family was assigned to a technology cluster and application.
The market side draws on regulatory databases such as FDA 510(k) and De Novo listings, company filings, clinical trial registries and peer-reviewed journals. Market figures are analyst estimates aligned to the stated forecast period.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
EMR’s AI-Guided Robotic Surgery Patent Landscape Analysis provides a comprehensive assessment of patent filings, innovation clusters, assignee portfolios, and geographic filing patterns across the AI-guided robotic surgery landscape. The report identifies 2,400+ patent families, evaluates leading jurisdictions including the United States, China, and Europe, and profiles the top assignees by portfolio size.
The global AI-guided robotic surgery market was valued at USD 3.15 Billion in 2025. The market is projected to reach USD 22.08 Billion by 2035, expanding at a CAGR of 21.50% during 2026-2035.
The report analyses approximately 2,400+ patent families related to AI-guided robotic surgery. These include filings from the United States, China, Europe, and international WIPO filings.
Key companies operating within the landscape include Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, Stryker, and Zimmer Biomet, among others. These organisations collectively account for a significant portion of patent activity analysed in this report.
The report evaluates patent activity across the United States, Europe, China, Japan, South Korea, India, and international WIPO filings. The United States leads patent activity, accounting for roughly 38% of families, followed by China and Europe.
Yes. The report scope can be customised based on geography, technology segment, assignee selection, time period, or specific innovation cluster focus. Please connect with the EMR team to define the customisation scope.
Patent landscape analysis helps organisations understand innovation trends, competitive activity, technology whitespace, and IP risk across a defined domain. For AI-guided robotic surgery, this report supports strategic decisions in R&D prioritisation, licensing evaluation, competitive benchmarking, and market entry planning.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
|
Scope of the Report |
Details |
|
Analysis by Technology |
|
|
Analysis by Application |
|
|
Analysis by Platform Type |
|
|
Analysis by End User |
|
|
Key Players Mentioned |
|
|
Geographies Covered |
|
Mini Report
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.